Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo

Osteoprotegerin (OPG) is a secreted member of the tumor necrosis factor (TNF) receptor superfamily that binds to the ligand for receptor activator of nuclear factor κB (RANKL) and inhibits bone resorption. OPG can also bind and inhibit the activity of the TNF‐related apoptosis‐inducing ligand (Apo2L...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Bone Miner Res
Main Authors: Zinonos, Irene, Labrinidis, Agatha, Lee, Michelle, Liapis, Vasilios, Hay, Shelley, Ponomarev, Vladimir, Diamond, Peter, Findlay, David M, Zannettino, Andrew CW, Evdokiou, Andreas
格式: Artigo
語言:Inglês
出版: Wiley Subscription Services, Inc., A Wiley Company 2011
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5568243/
https://ncbi.nlm.nih.gov/pubmed/20818644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.244
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍